Statistics for The Efficacy of Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancers: A Single-Center Real-Life Data Experience

Total visits

views
The Efficacy of Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancers: A Single-Center Real-Life Data Experience 0

Total visits per month

views
September 2025 0
October 2025 0
November 2025 0
December 2025 0
January 2026 0
February 2026 0
March 2026 0